Citations (103)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Matteo Bassetti, Maddalena Peghin, Alessio Mesini & Elio Castagnola. (2020) Optimal Management of Complicated Infections in the Pediatric Patient: The Role and Utility of Ceftazidime/Avibactam. Infection and Drug Resistance 13, pages 1763-1773.
Read now
Read now
George Dimopoulos, Despoina Koulenti, Suzanne L. Parker, Jason A. Roberts, Kostoula Arvaniti & Garyphalia Poulakou. (2019) Intravenous fosfomycin for the treatment of multidrug-resistant pathogens: what is the evidence on dosing regimens?. Expert Review of Anti-infective Therapy 17:3, pages 201-210.
Read now
Read now
Raghdaa A Ramadan, Manar G Gebriel, Heba M Kadry & Ahmed Mosallem. (2018) Carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: characterization of carbapenemase genes and E-test evaluation of colistin-based combinations. Infection and Drug Resistance 11, pages 1261-1269.
Read now
Read now
Norelle Sherry & Benjamin Howden. (2018) Emerging Gram negative resistance to last-line antimicrobial agents fosfomycin, colistin and ceftazidime-avibactam – epidemiology, laboratory detection and treatment implications. Expert Review of Anti-infective Therapy 16:4, pages 289-306.
Read now
Read now
Giulia Gustinetti, Giuliana Cangemi, Roberto Bandettini & Elio Castagnola. (2018) Pharmacokinetic/pharmacodynamic parameters for treatment optimization of infection due to antibiotic resistant bacteria: a summary for practical purposes in children and adults. Journal of Chemotherapy 30:2, pages 65-81.
Read now
Read now
Nadim G. El Chakhtoura, Elie Saade, Alina Iovleva, Mohamad Yasmin, Brigid Wilson, Federico Perez & Robert A. Bonomo. (2018) Therapies for multidrug resistant and extensively drug-resistant non-fermenting gram-negative bacteria causing nosocomial infections: a perilous journey toward ‘molecularly targeted’ therapy. Expert Review of Anti-infective Therapy 16:2, pages 89-110.
Read now
Read now
Philippe Montravers, Parvine Tashk & Alexy Tran Dinh. (2017) Unmet needs in the management of intra-abdominal infections. Expert Review of Anti-infective Therapy 15:9, pages 839-850.
Read now
Read now
Alexandre P. Zavascki, Brandon O. Klee & Jürgen B. Bulitta. (2017) Aminoglycosides against carbapenem-resistant Enterobacteriaceae in the critically ill: the pitfalls of aminoglycoside susceptibility. Expert Review of Anti-infective Therapy 15:6, pages 519-526.
Read now
Read now
Yiying Cai, Winnie Lee & Andrea L Kwa. (2015) Polymyxin B versus colistin: an update. Expert Review of Anti-infective Therapy 13:12, pages 1481-1497.
Read now
Read now
Sebastiano Barco, Roberto Bandettini, Angelo Maffia, Gino Tripodi, Elio Castagnola & Giuliana Cangemi. (2015) Quantification of piperacillin, tazobactam, meropenem, ceftazidime, and linezolid in human plasma by liquid chromatography/tandem mass spectrometry. Journal of Chemotherapy 27:6, pages 343-347.
Read now
Read now
Ilias Karaiskos & Helen Giamarellou. (2014) Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches. Expert Opinion on Pharmacotherapy 15:10, pages 1351-1370.
Read now
Read now
Articles from other publishers (92)
Zeqiang Xie, Jiyong Jian & Liang Chen. (2023) Analysis of Antimicrobial Susceptibility in Bacterial Pathogens Associated with Urinary Tract Infections from Beijing Teaching Hospital in China, 2009–2017. Canadian Journal of Infectious Diseases and Medical Microbiology 2023, pages 1-8.
Crossref
Crossref
Mohanraj Gopikrishnan, Sriroopreddy Ramireddy, Rinku Polachirakkal Varghese, Yamuna Devi Bakathavatchalam, Thirumal Kumar D, Abi Manesh, Kamini Walia, Balaji Veeraraghavan & George Priya Doss C. (2023)
Determination of potential combination of non‐β‐lactam, β‐lactam, and β‐lactamase inhibitors/β‐lactam enhancer against class D oxacillinases producing
Acinetobacter baumannii
: Evidence from
in‐vitro
, molecular docking and dynamics simulation
. Journal of Cellular Biochemistry 124:7, pages 974-988.
Crossref
Crossref
Mustafa Burak Acar, Şerife Ayaz-Güner, Hüseyin Güner, Gökçen Dinç, Ayşegül Ulu Kılıç, Mehmet Doğanay & Servet Özcan. (2022) A subtractive proteomics approach for the identification of immunodominant Acinetobacter baumannii vaccine candidate proteins. Frontiers in Immunology 13.
Crossref
Crossref
Inas El-Defrawy, Aisha Abu Aitta, Nevine Fam, Manar Khaled, Nadia Madany, Mervat El Damarawy, Doaa Gamal & Mohammed Amr Alkholy. (2022) In Vitro Activity of Single and Combined Antibiotics against Carbapenem Resistant Enterobacteriaceae Clinical Isolates in Relation to their Resistance Genes. Open Access Macedonian Journal of Medical Sciences 10:A, pages 1600-1607.
Crossref
Crossref
Miaomiao Xie, Kaichao Chen, Edward Wai-Chi Chan & Sheng Chen. (2022) Synergistic Antimicrobial Effect of Colistin in Combination with Econazole against Multidrug-Resistant Acinetobacter baumannii and Its Persisters. Microbiology Spectrum 10:3.
Crossref
Crossref
Namrata Kumari, Mukesh Kumar, Amit Katiyar, Abhay Kumar, Pallavi Priya, Bablu Kumar, Nihar Ranjan Biswas & Punit Kaur. (2022) Genome-wide identification of carbapenem-resistant Gram-negative bacterial (CR-GNB) isolates retrieved from hospitalized patients in Bihar, India. Scientific Reports 12:1.
Crossref
Crossref
Sara Mahmoud Farhan, Mohamed Raafat, Mohammed A. S. Abourehab, Rehab Mahmoud Abd El-Baky, Salah Abdalla, Ahmed Osama EL-Gendy & Ahmed Farag Azmy. (2021) Effect of Imipenem and Amikacin Combination against Multi-Drug Resistant Pseudomonas aeruginosa. Antibiotics 10:11, pages 1429.
Crossref
Crossref
Clement Yaw Effah, Emmanuel Kwateng Drokow, Clement Agboyibor, Shaohua Liu, Emmanuel Nuamah, Tongwen Sun, Lijun Miao, Jing Wang, Zhiwei Xu, Yongjun Wu & Xiaoju Zhang. (2021) Evaluation of the Therapeutic Outcomes of Antibiotic Regimen Against Carbapenemase-Producing Klebsiella pneumoniae: A Systematic Review and Meta-Analysis. Frontiers in Pharmacology 12.
Crossref
Crossref
Parnrada Nulsopapon, Worapong Nasomsong, Manat Pongchaidecha, Dhitiwat Changpradub, Piraporn Juntanawiwat & Wichai Santimaleeworagun. (2021) The Synergistic Activity and Optimizing Doses of Tigecycline in Combination with Aminoglycosides against Clinical Carbapenem-Resistant Klebsiella pneumoniae Isolates. Antibiotics 10:6, pages 736.
Crossref
Crossref
Gerlan Rocha-Santos, Gabriel T. Cuba, Rodrigo Cayô, Ana Paula Streling, Carolina S. Nodari, Ana C. Gales, Antonio C.C. Pignatari, David P. Nicolau & Carlos R.V. Kiffer. (2021) In vitro synergy of ticarcillin/clavulanate in combination with aztreonam and ceftolozane/tazobactam against SPM-1-producing Pseudomonas aeruginosa strains. Diagnostic Microbiology and Infectious Disease 100:2, pages 115343.
Crossref
Crossref
Yinzhi Lang, Nirav R. Shah, Xun Tao, Stephanie M. Reeve, Jieqiang Zhou, Bartolome Moya, Alaa R. M. Sayed, Suresh Dharuman, Jeremiah L. Oyer, Alicja J. Copik, Brett A. Fleischer, Eunjeong Shin, Carolin Werkman, Kari B. Basso, Deanna Deveson Lucas, Dhruvitkumar S. Sutaria, Marianne Mégroz, Tae Hwan Kim, Victoria Loudon‐Hossler, Amy Wright, Rossie H. Jimenez‐Nieves, Miranda J. Wallace, Keisha C. Cadet, Yuanyuan Jiao, John D. Boyce, Eric D. LoVullo, Herbert P. Schweizer, Robert A. Bonomo, Nagakumar Bharatham, Brian T. Tsuji, Cornelia B. Landersdorfer, Michael H. Norris, Beom Soo Shin, Arnold Louie, Venkataraman Balasubramanian, Richard E. Lee, George L. Drusano & Jürgen B. Bulitta. (2021) Combating Multidrug‐Resistant Bacteria by Integrating a Novel Target Site Penetration and Receptor Binding Assay Platform Into Translational Modeling. Clinical Pharmacology & Therapeutics 109:4, pages 1000-1020.
Crossref
Crossref
Tatyana A. PetrovskayaDmitry V. Tapalskiy. (2021) Influence of different antibiotic groups on the development of mutational resistance to colistin among Klebsiella pneumoniae. Clinical Microbiology and Antimicrobial Chemotherapy 23:2, pages 166-172.
Crossref
Crossref
Umit KilicMehmet KorogluMehmet OlmezMustafa Altindis. (2020)
Investigation of the
In Vitro
Effectiveness of Aztreonam/Avibactam, Colistin/Apramycin, and Meropenem/Apramycin Combinations Against Carbapenemase-Producing, Extensively Drug-Resistant
Klebsiella pneumoniae
Strains
. Microbial Drug Resistance 26:11, pages 1291-1297.
Crossref
Crossref
Phoebe C.M. Williams, Adam W. Bartlett, Pamela Palasanthiran, Benjamin Armstrong & Brendan J. McMullan. (2020) Successful treatment of invasive carbapenemase-producing Enterobacteriaceae infections in children using carbapenem–aminoglycoside combination therapy: A case series. Infection, Disease & Health 25:4, pages 314-318.
Crossref
Crossref
Temilolu Idowu, Derek Ammeter, Marc Brizuela, Gregory Jackson, Shadman Alam & Frank Schweizer. (2020) Overcoming β-Lactam resistance in Pseudomonas aeruginosa using non-canonical tobramycin-based antibiotic adjuvants. Bioorganic & Medicinal Chemistry Letters 30:21, pages 127575.
Crossref
Crossref
Paul Stoodley, Jacob Brooks, Casey W. Peters, Nan Jiang, Craig P. Delury, Phillip A. Laycock, Sean S. Aiken & Devendra H. Dusane. (2020) Prevention and Killing Efficacy of Carbapenem Resistant Enterobacteriaceae (CRE) and Vancomycin Resistant Enterococci (VRE) Biofilms by Antibiotic-Loaded Calcium Sulfate Beads. Materials 13:15, pages 3258.
Crossref
Crossref
Gabriel T Cuba, Gerlan Rocha-Santos, Rodrigo Cayô, Ana Paula Streling, Carolina S Nodari, Ana C Gales, Antonio C C Pignatari, David P Nicolau & Carlos R V Kiffer. (2020) In vitro synergy of ceftolozane/tazobactam in combination with fosfomycin or aztreonam against MDR Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy 75:7, pages 1874-1878.
Crossref
Crossref
Sungim Choi, Song Mi Moon, Su-Jin Park, Seung Cheol Lee, Kyung Hwa Jung, Heung-sup Sung, Mi-Na Kim, Jiwon Jung, Min Jae Kim, Sung-Han Kim, Sang-Oh Lee, Sang-Ho Choi, Jin-Yong Jeong, Jun Hee Woo, Yang Soo Kim & Yong Pil Chong. (2020)
Antagonistic Effect of Colistin on Vancomycin Activity against Methicillin-Resistant Staphylococcus aureus in
In Vitro
and
In Vivo
Studies
. Antimicrobial Agents and Chemotherapy 64:4.
Crossref
Crossref
Romina Papa-Ezdra, Fabio Grill Diaz, Mariela Vieytes, Virginia García-Fulgueiras, Leticia Caiata, Pablo Ávila, María Brasesco, Inés Christophersen, Nicolás F. Cordeiro, Gabriela Algorta, Antonio Galiana & Rafael Vignoli. (2020) First three Escherichia coli isolates harbouring mcr-1 in Uruguay. Journal of Global Antimicrobial Resistance 20, pages 187-190.
Crossref
Crossref
Hsiu-Ting Chien, Ying-Chi Lin, Chau-Chyun Sheu, Kun-Pin Hsieh & Jung-San Chang. (2020) Is colistin-associated acute kidney injury clinically important in adults? A systematic review and meta-analysis. International Journal of Antimicrobial Agents 55:3, pages 105889.
Crossref
Crossref
Fiona Hui-Sian Wong, Yiying Cai, Hui Leck, Tze-Peng Lim, Jocelyn Qi-Min Teo, Winnie Lee, Tse Hsien Koh, Thuan Tong Tan, Kar Wai Tan & Andrea Lay-Hoon Kwa. (2020) Determining the Development of Persisters in Extensively Drug-Resistant Acinetobacter baumannii upon Exposure to Polymyxin B-Based Antibiotic Combinations Using Flow Cytometry. Antimicrobial Agents and Chemotherapy 64:3.
Crossref
Crossref
Dmitry V. Tapalskiy, T.A. Petrovskaya, A.I. Kozlova & Mikhail V. Edelstein. (2020) Potentiation of antimicrobial activity of colistin with antibiotics of different groups against multidrug- and extensively drug-resistant strains of Klebsiella pneumoniae, Acinetobacter baumannii and Pseudomonas aeruginosa. Clinical Microbiology and Antimicrobial Chemotherapy 22:2, pages 128-136.
Crossref
Crossref
Roberto Vivas, Silvio Santana Dolabella, Ana Andréa Teixeira Barbosa & Sona Jain. (2020) Prevalence of Klebsiella pneumoniae carbapenemase - and New Delhi metallo-beta-lactamase-positive K. pneumoniae in Sergipe, Brazil, and combination therapy as a potential treatment option. Revista da Sociedade Brasileira de Medicina Tropical 53.
Crossref
Crossref
N. Jung, W.-J. Mayet, P.R. Mertens, J. Meyer (federführend)O.-A. Müller, M. Pfeifer, P. Schellinger, N. Weiss & C.-M. Wendtner. 2020. Rationelle Diagnostik und Therapie in der Inneren Medizin. Rationelle Diagnostik und Therapie in der Inneren Medizin
pL1
pL16.2-10
.
D. V. Tapalski, O. I. Savchenko & N. A. Bonda. (2019) Prevalence of carbapenemase-producing <i>Klebsiella pneumonia</i> in Gomel Region of Belarus and their sensitivity to antibiotics, antibiotic combinations, and decontaminants. Russian Journal of Infection and Immunity 9:5-6, pages 671-679.
Crossref
Crossref
Temilolu Idowu, Derek Ammeter, Gilbert Arthur, George G Zhanel & Frank Schweizer. (2019) Potentiation of β-lactam antibiotics and β-lactam/β-lactamase inhibitor combinations against MDR and XDR Pseudomonas aeruginosa using non-ribosomal tobramycin–cyclam conjugates. Journal of Antimicrobial Chemotherapy 74:9, pages 2640-2648.
Crossref
Crossref
Cheng Shi, Jiaxing Chen, Bin Xiao, Xinyue Kang, Xingzhen Lao & Heng Zheng. (2019) Discovery of NDM-1 inhibitors from natural products. Journal of Global Antimicrobial Resistance 18, pages 80-87.
Crossref
Crossref
James Albiero, Josmar Mazucheli, Juliana Pimenta dos Reis Barros, Marcia Maria dos Anjos Szczerepa, Sheila Alexandra Belini Nishiyama, Floristher Elaine Carrara-Marroni, Serubbabel Sy, Matthew Fidler, Sherwin K. B. Sy & Maria Cristina Bronharo Tognim. (2019) Pharmacodynamic Attainment of the Synergism of Meropenem and Fosfomycin Combination against Pseudomonas aeruginosa Producing Metallo-β-Lactamase. Antimicrobial Agents and Chemotherapy 63:6.
Crossref
Crossref
Jimin Xu, María Eugenia Pachón-Ibáñez, Tania Cebrero-Cangueiro, Haiying Chen, Javier Sánchez-Céspedes & Jia Zhou. (2019) Discovery of niclosamide and its O-alkylamino-tethered derivatives as potent antibacterial agents against carbapenemase-producing and/or colistin resistant Enterobacteriaceae isolates. Bioorganic & Medicinal Chemistry Letters 29:11, pages 1399-1402.
Crossref
Crossref
Gregory Saraiva Medeiros, Maria Helena Rigatto, Diego Rodrigues Falci & Alexandre P. Zavascki. (2019) Combination therapy with polymyxin B for carbapenemase-producing Klebsiella pneumoniae bloodstream infection. International Journal of Antimicrobial Agents 53:2, pages 152-157.
Crossref
Crossref
Jürgen B. Bulitta, Yuanyuan Jiao, Stefanie K. Drescher, Antonio Oliver, Arnold Louie, Bartolome Moya, Xun Tao, Mathias Wittau, Brian T. Tsuji, Alexandre P. Zavascki, Beom Soo Shin, George L. Drusano, Fritz Sörgel & Cornelia B. Landersdorfer. (2018) Four Decades of β-Lactam Antibiotic Pharmacokinetics in Cystic Fibrosis. Clinical Pharmacokinetics 58:2, pages 143-156.
Crossref
Crossref
Xiaojuan Wang, Qi Wang, Bin Cao, Shijun Sun, Yawei Zhang, Bing Gu, Binbin Li, Kang Liao, Feng Zhao, Liang Jin, Chunmei Jin, Chunxia Yang, Fengyan Pei, Zhijie Zhang & Hui Wang. (2019)
Retrospective Observational Study from a Chinese Network of the Impact of Combination Therapy versus Monotherapy on Mortality from Carbapenem-Resistant
Enterobacteriaceae
Bacteremia
. Antimicrobial Agents and Chemotherapy 63:1.
Crossref
Crossref
Maria Helena Rigatto, Diego R. Falci & Alexandre P. Zavascki. 2019. Polymyxin Antibiotics: From Laboratory Bench to Bedside. Polymyxin Antibiotics: From Laboratory Bench to Bedside
197
218
.
H.H. Abdel-Latif, N.G. Shams El-Din & H.A.H. Ibrahim. (2018)
Antimicrobial activity of the newly recorded red alga
Grateloupia doryphora
collected from the Eastern Harbor, Alexandria, Egypt
. Journal of Applied Microbiology 125:5, pages 1321-1332.
Crossref
Crossref
Yu Mi Wi & Cheol-In Kang. (2018) Antimicrobial Therapy for Infections Caused by Carbapenem-Resistant Gram-Negative Bacteria. The Korean Journal of Medicine 93:5, pages 439-446.
Crossref
Crossref
Ying Song, Lei Hu, Qiang Shu, Jing Ye, Jianfeng Liang, Xi Chen & Linhua Tan. (2018) Tigecycline salvage therapy for critically ill children with multidrug-resistant/extensively drug-resistant infections after surgery. International Journal of Infectious Diseases 75, pages 82-88.
Crossref
Crossref
Camila M. Wilhelm, Luciana de S. Nunes, Andreza F. Martins & Afonso L. Barth. (2018) In vitro antimicrobial activity of imipenem plus amikacin or polymyxin B against carbapenem-resistant Pseudomonas aeruginosa isolates. Diagnostic Microbiology and Infectious Disease 92:2, pages 152-154.
Crossref
Crossref
Yiying Cai, Celene L. Seah, Hui Leck, Tze-Peng Lim, Jocelyn Q. Teo, Winnie Lee, Thuan-Tong Tan, Tse-Hsien Koh, Pui Lai Rachel Ee & Andrea L. Kwa. (2018) Rapid Antibiotic Combination Testing for Carbapenem-Resistant Gram-Negative Bacteria within Six Hours Using ATP Bioluminescence. Antimicrobial Agents and Chemotherapy 62:9.
Crossref
Crossref
Lukose K. Thampy, Kenneth E. Remy, Andrew H. Walton, Zachery Hong, Kelilah Liu, Rebecca Liu, Victoria Yi, Carey-Ann D. Burnham & Richard S. Hotchkiss. (2018) Restoration of T Cell function in multi-drug resistant bacterial sepsis after interleukin-7, anti-PD-L1, and OX-40 administration. PLOS ONE 13:6, pages e0199497.
Crossref
Crossref
Christian Eckmann, Magnus Kaffarnik, Markus Schappacher, Robin Otchwemah & Béatrice Grabein. (2018) Multiresistente gramnegative BakterienMultidrug Resistant Gram-Negative Bacteria. Wiener klinisches Magazin 21:3, pages 112-123.
Crossref
Crossref
Prasanth Manohar, Thamaraiselvan Shanthini, Pandey Ekta, Mahesan J B, Kodiveri Muthukaliannan Gothandam, Bulent Bozdogan & Nachimuthu Ramesh. (2018) Colistin-Resistant Klebsiella pneumoniae: Prevalence of Integrons and Synergistic Out Turn for Colistin-Meropenem. Archives of Clinical Infectious Diseases 13:1.
Crossref
Crossref
Dmitry V. Tapalskiy. (2018) Susceptibility to antibiotic combinations among nosocomial carbapenemase-producing Gram-negative bacteria isolated in Belarus. Clinical Microbiology and Antimicrobial Chemotherapy 20:3, pages 182-191.
Crossref
Crossref
C. Eckmann, M. Kaffarnik, M. Schappacher, R. Otchwemah & B. Grabein. (2017) Multiresistente gramnegative BakterienMultidrug resistant gram-negative bacteria. Der Chirurg 89:1, pages 40-49.
Crossref
Crossref
Yossi Paitan. 2018. Escherichia coli, a Versatile Pathogen. Escherichia coli, a Versatile Pathogen
181
211
.
Rajbharan Yadav, Jürgen B. Bulitta, Jiping Wang, Roger L. Nation & Cornelia B. Landersdorfer. (2017) Evaluation of Pharmacokinetic/Pharmacodynamic Model-Based Optimized Combination Regimens against Multidrug-Resistant Pseudomonas aeruginosa in a Murine Thigh Infection Model by Using Humanized Dosing Schemes. Antimicrobial Agents and Chemotherapy 61:12.
Crossref
Crossref
Rajbharan Yadav, Jürgen B. Bulitta, Elena K. Schneider, Beom Soo Shin, Tony Velkov, Roger L. Nation & Cornelia B. Landersdorfer. (2017) Aminoglycoside Concentrations Required for Synergy with Carbapenems against Pseudomonas aeruginosa Determined via Mechanistic Studies and Modeling. Antimicrobial Agents and Chemotherapy 61:12.
Crossref
Crossref
Tina Khadem, Vanessa Stevens, Kathleen Holt, Charles Hoffmann, Ghinwa Dumyati & Jack Brown. (2017) Risk factors for carbapenem-nonsusceptible Pseudomonas aeruginosa : Case–control study. Diagnostic Microbiology and Infectious Disease 89:2, pages 146-150.
Crossref
Crossref
A. Peter R. Wilson. (2017) Sparing carbapenem usage. Journal of Antimicrobial Chemotherapy 72:9, pages 2410-2417.
Crossref
Crossref
Dennis Huang, Brenda Yu, John K. Diep, Rajnikant Sharma, Michael Dudley, Jussimara Monteiro, Keith S. Kaye, Jason M. Pogue, Cely Saad Abboud & Gauri G. Rao. (2017)
In Vitro
Assessment of Combined Polymyxin B and Minocycline Therapy against Klebsiella pneumoniae Carbapenemase (KPC)-Producing K. pneumoniae
. Antimicrobial Agents and Chemotherapy 61:7.
Crossref
Crossref
T. Tängdén, V. Ramos Martín, T. W. Felton, E. I. Nielsen, S. Marchand, R. J. Brüggemann, J. B. Bulitta, M. Bassetti, U. Theuretzbacher, B. T. Tsuji, D. W. Wareham, L. E. Friberg, J. J. De Waele, V. H. Tam & Jason A. Roberts. (2017) The role of infection models and PK/PD modelling for optimising care of critically ill patients with severe infections. Intensive Care Medicine 43:7, pages 1021-1032.
Crossref
Crossref
Biswajit Mishra & Guangshun Wang. (2017) Individual and Combined Effects of Engineered Peptides and Antibiotics on Pseudomonas aeruginosa Biofilms. Pharmaceuticals 10:3, pages 58.
Crossref
Crossref
Mareike Klinger-Strobel, Claudia Stein, Christina Forstner, Oliwia Makarewicz & Mathias W. Pletz. (2017) Effects of colistin on biofilm matrices of Escherichia coli and Staphylococcus aureus. International Journal of Antimicrobial Agents 49:4, pages 472-479.
Crossref
Crossref
Yongbo Zhang, Peizhen Li, Yuhan Yin, Fuqiang Li & Qinghua Zhang. (2016) In vitro activity of tigecycline in combination with rifampin, doripenem or ceftazidime against carbapenem-resistant Klebsiella pneumoniae bloodstream isolates. The Journal of Antibiotics 70:2, pages 193-195.
Crossref
Crossref
Young Woong Son, In Young JungMi Young AhnYong Duk JeonHea Won AnnJin Young AhnNam Su Ku, Sang Hoon HanJun Young ChoiYoung Goo SongJune Myung Kim. (2017)
A Case of Community-Acquired Pneumonia Caused by Multidrug-Resistant
Acinetobacter baumannii
in Korea
. Infection & Chemotherapy 49:4, pages 297.
Crossref
Crossref
Yiying Cai, Tze-Peng Lim, Jocelyn Qi-Min Teo, Suranthran Sasikala, Eric Chun Yong Chan, Yan Jun Hong, Winnie Lee, Thean Yen Tan, Thuan Tong Tan, Tse Hsien Koh, Li Yang Hsu & Andrea L. Kwa. (2017) Evaluating Polymyxin B-Based Combinations against Carbapenem-Resistant Escherichia coli in Time-Kill Studies and in a Hollow-Fiber Infection Model. Antimicrobial Agents and Chemotherapy 61:1.
Crossref
Crossref
Rajbharan Yadav, Jürgen B. Bulitta, Roger L. Nation & Cornelia B. Landersdorfer. (2017) Optimization of Synergistic Combination Regimens against Carbapenem- and Aminoglycoside-Resistant Clinical Pseudomonas aeruginosa Isolates via Mechanism-Based Pharmacokinetic/Pharmacodynamic Modeling. Antimicrobial Agents and Chemotherapy 61:1.
Crossref
Crossref
George L. Daikos, Maria Souli & Anastasia Antoniadou. 2017. Infectious Diseases. Infectious Diseases
1289
1292.e1
.
Yanhan Wang, Ming-Shan Kao, Jinghua Yu, Stephen Huang, Shinta Marito, Richard Gallo & Chun-Ming Huang. (2016) A Precision Microbiome Approach Using Sucrose for Selective Augmentation of Staphylococcus epidermidis Fermentation against Propionibacterium acnes. International Journal of Molecular Sciences 17:11, pages 1870.
Crossref
Crossref
Duck Jin Hong, Jung Ok Kim, Hyukmin Lee, Eun-Jeong Yoon, Seok Hoon Jeong, Dongeun Yong & Kyungwon Lee. (2016) In vitro antimicrobial synergy of colistin with rifampicin and carbapenems against colistin-resistant Acinetobacter baumannii clinical isolates. Diagnostic Microbiology and Infectious Disease 86:2, pages 184-189.
Crossref
Crossref
Abdulmajeed Ghanem Kraiem, Abdulaziz Zorgani, Omar Elahmer, Allaaeddin Ali El Salabi & Khalifa Sifaw Ghenghesh. (2016) Carbapenem-resistant gram-negative bacilli in Tripoli, Libya. American Journal of Infection Control 44:10, pages 1192-1194.
Crossref
Crossref
Yiying Cai, Tze-Peng Lim, Jocelyn Teo, Suranthran Sasikala, Winnie Lee, Yanjun Hong, Eric Chun Yong Chan, Thean Yen Tan, Thuan-Tong Tan, Tse Hsien Koh, Li Yang Hsu & Andrea L. Kwa. (2016)
In Vitro
Activity of Polymyxin B in Combination with Various Antibiotics against Extensively Drug-Resistant Enterobacter cloacae with Decreased Susceptibility to Polymyxin B
. Antimicrobial Agents and Chemotherapy 60:9, pages 5238-5246.
Crossref
Crossref
Andrea Cortegiani, Vincenzo Russotto, Giorgio Graziano, Daniela Geraci, Laura Saporito, Gianfranco Cocorullo, Santi Maurizio Raineri, Caterina Mammina & Antonino Giarratano. (2016) Use of Cepheid Xpert Carba-R® for Rapid Detection of Carbapenemase-Producing Bacteria in Abdominal Septic Patients Admitted to Intensive Care Unit. PLOS ONE 11:8, pages e0160643.
Crossref
Crossref
Yiying Cai, Nathalie Grace Chua, Tze-Peng Lim, Jocelyn Qi-Min Teo, Winnie Lee, Asok Kurup, Tse-Hsien Koh, Thuan-Tong Tan & Andrea L. Kwa. (2016) From Bench-Top to Bedside: A Prospective In Vitro Antibiotic Combination Testing (iACT) Service to Guide the Selection of Rationally Optimized Antimicrobial Combinations against Extensively Drug Resistant (XDR) Gram Negative Bacteria (GNB). PLOS ONE 11:7, pages e0158740.
Crossref
Crossref
James Albiero, Sherwin K. B. Sy, Josmar Mazucheli, Silvana Martins Caparroz-Assef, Bruno Buranello Costa, Janio Leal Borges Alves, Ana Cristina Gales & Maria Cristina Bronharo Tognim. (2016) Pharmacodynamic Evaluation of the Potential Clinical Utility of Fosfomycin and Meropenem in Combination Therapy against KPC-2-Producing Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy 60:7, pages 4128-4139.
Crossref
Crossref
Jasna Hrenovic, Ivana Goic-Barisic, Snjezana Kazazic, Ana Kovacic, Marin Ganjto & Marija Tonkic. (2016) Carbapenem-resistant isolates of Acinetobacter baumannii in a municipal wastewater treatment plant, Croatia, 2014. Eurosurveillance 21:15.
Crossref
Crossref
Le Zhai, Yi-Lin Zhang, Joon S. Kang, Peter Oelschlaeger, Lin Xiao, Sha-Sha Nie & Ke-Wu Yang. (2016) Triazolylthioacetamide: A Valid Scaffold for the Development of New Delhi Metallo-β-Lactmase-1 (NDM-1) Inhibitors. ACS Medicinal Chemistry Letters 7:4, pages 413-417.
Crossref
Crossref
Hyukmin Lee, Kyung Ho Roh, Seong Geun Hong, Hee Bong Shin, Seok Hoon Jeong, Wonkeun Song, Young Uh, Dongeun Yong & Kyungwon Lee. (2016)
In Vitro
Synergistic Effects of Antimicrobial Combinations on Extensively Drug-Resistant
Pseudomonas aeruginosa
and
Acinetobacter baumannii
Isolates
. Annals of Laboratory Medicine 36:2, pages 138-144.
Crossref
Crossref
Alejandro Díaz, Diana Cristina Ortiz, Mónica Trujillo, Carlos Garcés, Fabian Jaimes & Andrea Victoria Restrepo. (2016) Clinical Characteristics of Carbapenem-resistant Klebsiella pneumoniae Infections in Ill and Colonized Children in Colombia. Pediatric Infectious Disease Journal 35:3, pages 237-241.
Crossref
Crossref
A. Xu, B. Zheng, Y.-C. Xu, Z.-G. Huang, N.-S. Zhong & C. Zhuo. (2016) National epidemiology of carbapenem-resistant and extensively drug-resistant Gram-negative bacteria isolated from blood samples in China in 2013. Clinical Microbiology and Infection 22, pages S1-S8.
Crossref
Crossref
A. Isla, A. Canut, J. Arribas, E. Asín-Prieto & A. Rodríguez-Gascón. (2016) Meropenem dosing requirements against Enterobacteriaceae in critically ill patients: influence of renal function, geographical area and presence of extended-spectrum β-lactamases. European Journal of Clinical Microbiology & Infectious Diseases 35:3, pages 511-519.
Crossref
Crossref
Jocelyn Teo, Yiying Cai, Tze-Peng Lim, Thuan Tan & Andrea Kwa. (2016) Carbapenem Resistance in Gram-Negative Bacteria: The Not-So-Little Problem in the Little Red Dot. Microorganisms 4:1, pages 13.
Crossref
Crossref
Neelam YanejaHarsimran Kaur. (2016) Insights into Newer Antimicrobial Agents against Gram-negative Bacteria. Microbiology Insights 9, pages MBI.S29459.
Crossref
Crossref
C Sánchez Ramirez, L Caipe Balcázar, MA Hernández Viera, M Cabrera Santana, S Hípola Escalada, N Sangil Monroy, F Artiles Campelo, CF Lübbe Vazquez, MA De la Cal Lòpez & S Ruiz Santana. (2015) Impact after 3 years of application of enteral paromomycin to eradicate colistin and carbepemenase resistant microrganisms in rectal colonization to prevent ICU infections. Intensive Care Medicine Experimental 3:S1.
Crossref
Crossref
Mahableshwar S. Albur, Alan Noel, Karen Bowker & Alasdair MacGowan. (2015) The combination of colistin and fosfomycin is synergistic against NDM-1-producing Enterobacteriaceae in in vitro pharmacokinetic/pharmacodynamic model experiments. International Journal of Antimicrobial Agents 46:5, pages 560-567.
Crossref
Crossref
Yiying Cai, Hui Leck, Tze Peng Lim, Jocelyn Teo, Winnie Lee, Li Yang Hsu, Tse Hsien Koh, Thuan Tong Tan, Thean-Yen Tan & Andrea Lay-Hoon Kwa. (2015) Using an Adenosine Triphosphate Bioluminescent Assay to Determine Effective Antibiotic Combinations against Carbapenem-Resistant Gram Negative Bacteria within 24 Hours. PLOS ONE 10:10, pages e0140446.
Crossref
Crossref
Johann D. D. Pitout, Patrice Nordmann & Laurent Poirel. (2015) Carbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial Dominance. Antimicrobial Agents and Chemotherapy 59:10, pages 5873-5884.
Crossref
Crossref
Maria Helena Rigatto, Fabiane J. Vieira, Laura C. Antochevis, Tainá F. Behle, Natane T. Lopes & Alexandre P. Zavascki. (2015)
Polymyxin B in Combination with Antimicrobials Lacking
In Vitro
Activity versus Polymyxin B in Monotherapy in Critically Ill Patients with Acinetobacter baumannii or Pseudomonas aeruginosa Infections
. Antimicrobial Agents and Chemotherapy 59:10, pages 6575-6580.
Crossref
Crossref
Helio S. Sader, Mariana Castanheira, Robert K. Flamm, Rodrigo E. Mendes, David J. Farrell & Ronald N. Jones. (2015) Tigecycline activity tested against carbapenem-resistant Enterobacteriaceae from 18 European nations: results from the SENTRY surveillance program (2010–2013). Diagnostic Microbiology and Infectious Disease 83:2, pages 183-186.
Crossref
Crossref
Paula Virginia Michelon Toledo, Ayrton Alves Aranha Junior, Lavinia Nery Arend, Vanessa Ribeiro, Alexandre Prehn Zavascki & Felipe Francisco Tuon. (2015) Activity of Antimicrobial Combinations against KPC-2-Producing Klebsiella pneumoniae in a Rat Model and Time-Kill Assay. Antimicrobial Agents and Chemotherapy 59:7, pages 4301-4304.
Crossref
Crossref
Yaping Chang, Sean Alexander Kennedy, Mohit Bhandari, Luciane Cruz Lopes, Cristiane de Cássia Bergamaschi, Maria Carolina de Oliveira e Silva, Neera Bhatnagar, S. Mohsen Mousavi, Saqib Khurshid, Brad Petrisor, Melody Ren, Sukhmani K. Sodhi, Reza Donald Mirza & Gordon H. Guyatt. (2015) Effects of Antibiotic Prophylaxis in Patients with Open Fracture of the Extremities. JBJS Reviews 3:6.
Crossref
Crossref
Natália Barth, Vanessa B. Ribeiro & Alexandre P. Zavascki. (2015)
In Vitro
Activity of Polymyxin B plus Imipenem, Meropenem, or Tigecycline against KPC-2-Producing Enterobacteriaceae with High MICs for These Antimicrobials
. Antimicrobial Agents and Chemotherapy 59:6, pages 3596-3597.
Crossref
Crossref
Maristela P. Freire, Edson Abdala, Maria L. Moura, Flávio Jota de Paula, Fernanda Spadão, Hélio H. Caiaffa-Filho, Elias David-Neto, William C. Nahas & Ligia C. Pierrotti. (2015) Risk factors and outcome of infections with Klebsiella pneumoniae carbapenemase-producing K. pneumoniae in kidney transplant recipients. Infection 43:3, pages 315-323.
Crossref
Crossref
Maria Helena Rigatto, Tainá F. Behle, Diego R. Falci, Thiela Freitas, Natane T. Lopes, Mariá Nunes, Leonardo W. Costa & Alexandre P. Zavascki. (2015) Risk factors for acute kidney injury (AKI) in patients treated with polymyxin B and influence of AKI on mortality: a multicentre prospective cohort study. Journal of Antimicrobial Chemotherapy 70:5, pages 1552-1557.
Crossref
Crossref
Jürgen B. Bulitta, Neang S. Ly, Cornelia B. Landersdorfer, Nicholin A. Wanigaratne, Tony Velkov, Rajbharan Yadav, Antonio Oliver, Lisandra Martin, Beom Soo Shin, Alan Forrest & Brian T. Tsuji. (2015) Two Mechanisms of Killing of Pseudomonas aeruginosa by Tobramycin Assessed at Multiple Inocula via Mechanism-Based Modeling. Antimicrobial Agents and Chemotherapy 59:4, pages 2315-2327.
Crossref
Crossref
Haley J. Morrill, Jason M. Pogue, Keith S. Kaye & Kerry L. LaPlante. (2015) Treatment Options for Carbapenem-Resistant Enterobacteriaceae Infections. Open Forum Infectious Diseases 2:2.
Crossref
Crossref
Cheol-In Kang. (2015) Antimicrobial Therapy for Infections Caused by Multidrug-Resistant Gram-Negative Bacteria. Korean Journal of Medicine 88:5, pages 502.
Crossref
Crossref
Fortunata Lombardi, Paola Gaia, Rea Valaperta, Maria Cornetta, Milvana Rosa Tejada, Luca Di Girolamo, Alessandra Moroni, Federica Ramundo, Alessio Colombo, Massimiliano Valisi & Elena Costa. (2015)
Emergence of Carbapenem-Resistant
Klebsiella pneumoniae
: Progressive Spread and Four-Year Period of Observation in a Cardiac Surgery Division
. BioMed Research International 2015, pages 1-7.
Crossref
Crossref
Gian Maria Rossolini, Fabio Arena, Patrizia Pecile & Simona Pollini. (2014) Update on the antibiotic resistance crisis. Current Opinion in Pharmacology 18, pages 56-60.
Crossref
Crossref
L.S. Tzouvelekis, A. Markogiannakis, E. Piperaki, M. Souli & G.L. Daikos. (2014) Treating infections caused by carbapenemase-producing Enterobacteriaceae. Clinical Microbiology and Infection 20:9, pages 862-872.
Crossref
Crossref
V. Cattoir. (2014) Traitement des infections dues à entérobactéries productrices de carbapénèmases. Journal des Anti-infectieux 16:3, pages 99-105.
Crossref
Crossref
Virve I. Enne, Yoann Personne, Ljuban Grgic, Vanya Gant & Alimuddin Zumla. (2014) Aetiology of hospital-acquired pneumonia and trends in antimicrobial resistance. Current Opinion in Pulmonary Medicine 20:3, pages 252-258.
Crossref
Crossref
Helio S. Sader, David J. Farrell, Robert K. Flamm & Ronald N. Jones. (2014) Variation in Potency and Spectrum of Tigecycline Activity against Bacterial Strains from U.S. Medical Centers since Its Approval for Clinical Use (2006 to 2012). Antimicrobial Agents and Chemotherapy 58:4, pages 2274-2280.
Crossref
Crossref